The Role of COL22A1 in the Pathophysiology of Hepatocellular Carcinoma: Evidence from Bioinformatics Exploration

References

• Clark T, Maximin S, Meier J, Pokharel S, Bhargava P. Hepatocellular carcinoma: review of epidemiology, screening, imaging diagnosis, response assessment, and treatment. Curr Probl Diagn Radiol. 2015;44(6):479–486. doi:10.1067/j.cpradiol.2015.04.004
   PubMed Web of Science ®Google Scholar
• Llovet JM, Montal R, Sia D, Finn RS. Molecular therapies and precision medicine for hepatocellular carcinoma. Nat Rev Clin Oncol. 2018;15(10):599–616. doi:10.1038/s41571-018-0073-4
   PubMed Web of Science ®Google Scholar
• Xia S, Pan Y, Liang Y, Xu J, Cai X. The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma. EBioMedicine. 2020;51:102610. doi:10.1016/j.ebiom.2019.102610
   PubMed Web of Science ®Google Scholar
• Huang X, Liu S, Wu L, Jiang M, Hou Y. High throughput single cell RNA sequencing, bioinformatics analysis and applications. Adv Exp Med Biol. 2018;1068:33–43.
   PubMed Web of Science ®Google Scholar
• Rego SM, Snyder MP. High throughput sequencing and assessing disease risk. Cold Spring Harb Perspect Med. 2019;9(1). doi:10.1101/cshperspect.a026849
   PubMed Web of Science ®Google Scholar
• Reuter JA, Spacek DV, Snyder MP. High-throughput sequencing technologies. Mol Cell. 2015;58(4):586–597. doi:10.1016/j.molcel.2015.05.004
   PubMed Web of Science ®Google Scholar
• Zheng C, Zheng L, Yoo JK, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169(7):1342–1356.e1316. doi:10.1016/j.cell.2017.05.035
   PubMed Web of Science ®Google Scholar
• Chen H, Gao F, He M, et al. Long-read RNA sequencing identifies alternative splice variants in hepatocellular carcinoma and tumor-specific isoforms. Hepatology. 2019;70(3):1011–1025. doi:10.1002/hep.30500
   PubMed Web of Science ®Google Scholar
• Hu ZQ, Zhou SL, Li J, et al. Circular RNA sequencing identifies CircASAP1 as a key regulator in hepatocellular carcinoma metastasis. Hepatology. 2020;72(3):906–922. doi:10.1002/hep.31068
   PubMed Web of Science ®Google Scholar
• Zhang C, Peng L, Zhang Y, et al. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Med Oncol. 2017;34(6):101. doi:10.1007/s12032-017-0963-9
   PubMed Web of Science ®Google Scholar
• Xiong DD, Dang YW, Lin P, et al. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med. 2018;16(1):220. doi:10.1186/s12967-018-1593-5
   PubMed Web of Science ®Google Scholar
• Lou W, Liu J, Ding B, et al. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC. J Transl Med. 2019;17(1):7. doi:10.1186/s12967-018-1761-7
   PubMed Web of Science ®Google Scholar
• Tomczak A, Mortensen JM, Winnenburg R, et al. Interpretation of biological experiments changes with evolution of the Gene Ontology and its annotations. Sci Rep. 2018;8(1):5115. doi:10.1038/s41598-018-23395-2
   PubMed Web of Science ®Google Scholar
• Uphoff CC, Drexler HG. Detection of mycoplasma in leukemia-lymphoma cell lines using polymerase chain reaction. Leukemia. 2002;16(2):289–293. doi:10.1038/sj.leu.2402365
   PubMed Web of Science ®Google Scholar
• Schlachterman A, Craft WW, Hilgenfeldt E, Mitra A, Cabrera R. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol. 2015;21(28):8478–8491. doi:10.3748/wjg.v21.i28.8478
   PubMed Web of Science ®Google Scholar
• Hooks KB, Audoux J, Fazli H, et al. New insights into diagnosis and therapeutic options for proliferative hepatoblastoma. Hepatology. 2018;68(1):89–102. doi:10.1002/hep.29672
   PubMed Web of Science ®Google Scholar
• Zhao J, Zhu XC, Wu XS, et al. Identification of miR-4644 as a suitable endogenous normalizer for circulating miRNA quantification in hepatocellular carcinoma. J Cancer. 2020;11(23):7032–7044. doi:10.7150/jca.48903
   PubMed Web of Science ®Google Scholar
• Chan TH, Lin CH, Qi L, et al. A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma. Gut. 2014;63(5):832–843. doi:10.1136/gutjnl-2012-304037
   PubMed Web of Science ®Google Scholar
• Misawa K, Kanazawa T, Imai A, et al. Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients. Mol Clin Oncol. 2014;2(2):285–291. doi:10.3892/mco.2013.233
   PubMedGoogle Scholar
• Ma H, Tong L, Zhang Q, Chang W, Li F. Identification of 5 gene signatures in survival prediction for patients with lung squamous cell carcinoma based on integrated multiomics data analysis. Biomed Res Int. 2020;2020:6427483. doi:10.1155/2020/6427483
   PubMed Web of Science ®Google Scholar
• Guo T, Wang H, Liu P, et al. SNHG6 acts as a genome-wide hypomethylation trigger via coupling of miR-1297-mediated S-adenosylmethionine-dependent positive feedback loops. Cancer Res. 2018;78(14):3849–3864. doi:10.1158/0008-5472.CAN-17-3833
   PubMed Web of Science ®Google Scholar
• Cao Y, Tao Q, Kao X, Zhu X. Hsa-circRNA-103809 promotes hepatocellular carcinoma development via microRNA-1270/PLAG1 like zinc finger 2 axis. Dig Dis Sci. 2021;66(5):1524–1532. doi:10.1007/s10620-020-06416-x
   PubMed Web of Science ®Google Scholar
• Yuan YL, Yu H, Mu SM, Dong YD, Li Y. MiR-26a-5p inhibits cell proliferation and enhances doxorubicin sensitivity in HCC cells via targeting AURKA. Technol Cancer Res Treat. 2019;18:1533033819851833. doi:10.1177/1533033819851833
   Web of Science ®Google Scholar
• Hu X, Wang R, Ren Z, et al. MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/β-catenin signaling. Cancer Med. 2019;8(17):7359–7371. doi:10.1002/cam4.2613
   PubMed Web of Science ®Google Scholar
• Wu H, Zhang W, Wu Z, et al. miR-29c-3p regulates DNMT3B and LATS1 methylation to inhibit tumor progression in hepatocellular carcinoma. Cell Death Dis. 2019;10(2):48. doi:10.1038/s41419-018-1281-7
   PubMed Web of Science ®Google Scholar
• Fang JH, Zhou HC, Zeng C, et al. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology. 2011;54(5):1729–1740. doi:10.1002/hep.24577
   PubMed Web of Science ®Google Scholar
• Mahati S, Xiao L, Yang Y, Mao R, Bao Y. miR-29a suppresses growth and migration of hepatocellular carcinoma by regulating CLDN1. Biochem Biophys Res Commun. 2017;486(3):732–737. doi:10.1016/j.bbrc.2017.03.110
   PubMed Web of Science ®Google Scholar